Pentostatin

CHEMBL1580 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

268.3 g/mol

LogP

-2.1

Phase

4

This chemotherapy drug treats hairy cell leukemia by blocking an enzyme leukemia cells need to survive.

Peso molecular

268,2700 g/mol

LogP

-2,10

TPSA

112,00 Å²

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Cáncer de vejiga Leucemia Linfoma VIH/sida

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

OC[C@H]1O[C@@H](n2cnc3c2N=CNC[C@H]3O)C[C@@H]1O

InChI

InChI=1S/C11H16N4O4/c16-3-8-6(17)1-9(19-8)15-5-14-10-7(18)2-12-4-13-11(10)15/h4-9,16-18H,1-3H2,(H,12,13)/t6-,7+,8+,9+/m0/s1

Molecular Formula

C11H16N4O4

HBD / HBA

4 / 6

Enlaces Rotables

2

Átomos Pesados

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

This chemotherapy drug treats hairy cell leukemia by blocking an enzyme leukemia cells need to survive.

Yes, Pentostatin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1580. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 439693. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

¿Busca información accesible para el paciente?

Pentostatin en PillFYI

Estructura

Datos Rápidos

Fórmula: C11H16N4O4
Sinónimos: 1

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.